E. V. Zhdanova
E. V. Zhdanova has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- I. S. Tyumentseva
Stavropol Research Anti-Plague Institute
3 shared publications - I. V. Zharnikova
Stavropol Research Anti-Plague Institute
3 shared publications - S. A. Kurcheva
Stavropol Research Anti-Plague Institute
3 shared publications - A. A. Semircheva
Stavropol Research Anti-Plague Institute
2 shared publications - A. G. Koshkid’kO
Stavropol Research Anti-Plague Institute
2 shared publications - D. V. Rusanova
Stavropol Research Anti-Plague Institute
2 shared publications
Latest Publications
- Open Access
- 2 June 2022
- Published by SCEEMP in Biological Products. Prevention, Diagnosis, Treatment
- Vol. 22 (2) , 196-207-207
Development of a protective lyophilisation medium and conditions to stabilise the erythrocyte diagnostic preparation of tularaemia immunoglobulin
Liquid erythrocyte diagnostic preparations have a practical disadvantage; i.e., long-distance transportation involving possible non-compliance with cold-chain requirements may result in a complete loss of biological activity. A lyophilisation technology is necessary to ensure that the preparations retain their original properties for a long time. The aim of the work was to develop a protective medium and conditions for lyophilisation to stabilise the erythrocyte diagnostic preparation of tularaemia immunoglobulin. Materials and methods: Gelatin, thiourea, trehalose, sucrose, dextran, and Tween 80 were used as excipients for protective media. The authors used nine strains of homologous and heterologous microorganisms of different genera and species to control the lyophilised diagnostic preparation sensitivity and specificity. Evaluation of the main stability-related quality attributes (appearance of the dried preparation, loss on drying, solubility, appearance after reconstitution, appearance after settling, sensitivity, specificity) considered the temperatures specific to the climatic zones where the in vitro diagnostics is intended to be marketed and used. Results: The authors developed protective stabilising media with different compositions, used them in freeze-drying of the preparation and carried out control testing. The most promising was the lyophilisation medium containing a smaller amount of ingredients —6% of dextran, 0.06% of Tween 80 and up to 0.01% of sodium azide—as it was the simplest one to prepare and ensured complete preservation of the quality attributes. The authors carried out practical evaluation of lyophilisation procedures, and the 12–14-hour procedure proved to be the most cost-effective. Conclusions: The results of long-term, or real time, and accelerated stability testing of the lyophilised diagnostic preparation demonstrated the possibility of two-year storage at a labelled temperature of 2–8 °C, as well as at elevated and low temperatures of 30±2 °С and –18 °С, respectively. The tests showed no negative effects of the temperatures on the controlled quality attributes.
- 2 June 2022
- Published by SCEEMP in Biological Products. Prevention, Diagnosis, Treatment
- Vol. 22 (2) , 196-207-207
Open AccessDevelopment of a protective lyophilisation medium and conditions to stabilise the erythrocyte diagnostic preparation of tularaemia immunoglobulin
Liquid erythrocyte diagnostic preparations have a practical disadvantage; i.e., long-distance transportation involving possible non-compliance with cold-chain requirements may result in a complete loss of biological activity. A lyophilisation technology is necessary to ensure that the preparations retain their original properties for a long time. The aim of the work was to develop a protective medium and conditions for lyophilisation to stabilise the erythrocyte diagnostic preparation of tularaemia immunoglobulin. Materials and methods: Gelatin, thiourea, trehalose, sucrose, dextran, and Tween 80 were used as excipients for protective media. The authors used nine strains of homologous and heterologous microorganisms of different genera and species to control the lyophilised diagnostic preparation sensitivity and specificity. Evaluation of the main stability-related quality attributes (appearance of the dried preparation, loss on drying, solubility, appearance after reconstitution, appearance after settling, sensitivity, specificity) considered the temperatures specific to the climatic zones where the in vitro diagnostics is intended to be marketed and used. Results: The authors developed protective stabilising media with different compositions, used them in freeze-drying of the preparation and carried out control testing. The most promising was the lyophilisation medium containing a smaller amount of ingredients —6% of dextran, 0.06% of Tween 80 and up to 0.01% of sodium azide—as it was the simplest one to prepare and ensured complete preservation of the quality attributes. The authors carried out practical evaluation of lyophilisation procedures, and the 12–14-hour procedure proved to be the most cost-effective. Conclusions: The results of long-term, or real time, and accelerated stability testing of the lyophilised diagnostic preparation demonstrated the possibility of two-year storage at a labelled temperature of 2–8 °C, as well as at elevated and low temperatures of 30±2 °С and –18 °С, respectively. The tests showed no negative effects of the temperatures on the controlled quality attributes.
- Open Access
- 26 January 2022
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 79-83
Assessment of the Application of Erythrocytal Diagnosticum (Lyophilizate) in Detecting Tularemia Agent in Natural Foci
Tularemia is a zoonotic disease with a wide geographical dissemination, and its causative agent Francisella tularensis can be used as a bioterrorism agent. The aim of the study was to evaluate the use of a set of reagents “Erythrocytic immunoglobulin dry tularemia diagnosticum” (“DET-Ig”) with the help of control test strains and field material from natural tularemia foci. Materials and methods. Using the introduced erythrocyte diagnosticum, we studied the decontaminated cultures of test strains (F. tularensis Miura, F. tularensis 55, F. tularensis Schu, F. tularensis 15 NIIEG, Brucella abortus 544, B. melitensis 16-M, B. suis 1330, and Yersinia enterocolitica 64, Y. enterocolitica 178, Y. enterocolitica 383) and environmental samples suspected of containing F. tularensis. Results and discussion. It has been proven that the developed diagnosticum is specific, sensitive, and easy to use for routine diagnostics of tularemia. In the course of laboratory tests of the experimental series of the DET-Ig reagent kit, the possibility of qualitative determination of the tularemia agent in bacterial cultures, biological material and environmental samples in the reaction of indirect hemagglutination was demonstrated. Comparison of the results of use of erythrocyte diagnosticum in liquid and lyophilized forms showed the advantages of drugs after lyophilization: the possibility of transportation and long-term storage at any temperature conditions in various climatic conditions; the setting of the reaction is possible without the use of special diluents. The guaranteed storage term is set for two years (observation period). The results obtained indicate the prospects of introducing the developed drug into healthcare practice.
- 26 January 2022
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 79-83
Open AccessAssessment of the Application of Erythrocytal Diagnosticum (Lyophilizate) in Detecting Tularemia Agent in Natural Foci
Tularemia is a zoonotic disease with a wide geographical dissemination, and its causative agent Francisella tularensis can be used as a bioterrorism agent. The aim of the study was to evaluate the use of a set of reagents “Erythrocytic immunoglobulin dry tularemia diagnosticum” (“DET-Ig”) with the help of control test strains and field material from natural tularemia foci. Materials and methods. Using the introduced erythrocyte diagnosticum, we studied the decontaminated cultures of test strains (F. tularensis Miura, F. tularensis 55, F. tularensis Schu, F. tularensis 15 NIIEG, Brucella abortus 544, B. melitensis 16-M, B. suis 1330, and Yersinia enterocolitica 64, Y. enterocolitica 178, Y. enterocolitica 383) and environmental samples suspected of containing F. tularensis. Results and discussion. It has been proven that the developed diagnosticum is specific, sensitive, and easy to use for routine diagnostics of tularemia. In the course of laboratory tests of the experimental series of the DET-Ig reagent kit, the possibility of qualitative determination of the tularemia agent in bacterial cultures, biological material and environmental samples in the reaction of indirect hemagglutination was demonstrated. Comparison of the results of use of erythrocyte diagnosticum in liquid and lyophilized forms showed the advantages of drugs after lyophilization: the possibility of transportation and long-term storage at any temperature conditions in various climatic conditions; the setting of the reaction is possible without the use of special diluents. The guaranteed storage term is set for two years (observation period). The results obtained indicate the prospects of introducing the developed drug into healthcare practice.
- Open Access
- 1 April 2020
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Development of Immunodiagnostic Preparations for Detection of the Plague Pathogen (Capsular and Capsule-Free Forms)
Introduction: Plague is endemic in a number of states around the world. Despite all public health measures taken to eradicate plague, the disease persists and even reappears in some countries. Today, traditional serological methods searching for the capsular antigen of the plague microbe are widely used to monitor the presence of Y. pestis in the environment. Yet, for the causative agent of the plague, the possibility of eliminating plasmids and maintaining of the ability to cause an infectious process by atypical strains is not excluded, which reduces the diagnostic value of preparations based on the detection of species-specific antigens of the plague microbe. Our objective was to develop biotechnology for the production of immunodiagnostic drugs for detection of the plague bacteria (capsular and capsule-free forms). Materials and methods: When performing the work, 27 strains of microorganisms of pathogenicity groups I–IV of different genera and species were used. Results: The development of immunodiagnostic preparations for the detection of Y. pestis in environmental samples is described. The presented experimental preparations allow detection of typical and antigenically modified plague microbe strains with a positive and/or negative expression of fraction 1. To evaluate the effectiveness of the designed diagnosticums, both laboratory and field testing was performed demonstrating positive results in the study of both artificially and naturally contaminated samples. The possibility of using the plague immunomagnetic sorbent providing selective concentration of material with a low pathogen content and purification of samples from possible contamination with extraneous microflora during epizootological examination was also confirmed. Conclusions: We constructed promising diagnostic preparations that help identify Y. pestis strains in the studied objects regardless of the cultivation temperature and plasmid profile.
- 1 April 2020
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Open AccessDevelopment of Immunodiagnostic Preparations for Detection of the Plague Pathogen (Capsular and Capsule-Free Forms)
Introduction: Plague is endemic in a number of states around the world. Despite all public health measures taken to eradicate plague, the disease persists and even reappears in some countries. Today, traditional serological methods searching for the capsular antigen of the plague microbe are widely used to monitor the presence of Y. pestis in the environment. Yet, for the causative agent of the plague, the possibility of eliminating plasmids and maintaining of the ability to cause an infectious process by atypical strains is not excluded, which reduces the diagnostic value of preparations based on the detection of species-specific antigens of the plague microbe. Our objective was to develop biotechnology for the production of immunodiagnostic drugs for detection of the plague bacteria (capsular and capsule-free forms). Materials and methods: When performing the work, 27 strains of microorganisms of pathogenicity groups I–IV of different genera and species were used. Results: The development of immunodiagnostic preparations for the detection of Y. pestis in environmental samples is described. The presented experimental preparations allow detection of typical and antigenically modified plague microbe strains with a positive and/or negative expression of fraction 1. To evaluate the effectiveness of the designed diagnosticums, both laboratory and field testing was performed demonstrating positive results in the study of both artificially and naturally contaminated samples. The possibility of using the plague immunomagnetic sorbent providing selective concentration of material with a low pathogen content and purification of samples from possible contamination with extraneous microflora during epizootological examination was also confirmed. Conclusions: We constructed promising diagnostic preparations that help identify Y. pestis strains in the studied objects regardless of the cultivation temperature and plasmid profile.
- Open Access
- 20 December 2013
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 76-78-78
Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
Разработана и апробирована тест-система для обнаружения антител к возбудителю сибирской язвы непрямым методом флуоресцирующих антител. Набор включает в себя антигенный препарат, положительный контрольный образец, отрицательный контрольный образец, ФИТЦ-конъюгат кроличьих антител. Изучены 10 акапсульных штаммов B. anthracis с различным плазмидным составом и морфологией колоний. Установлено, что в качестве антигенного препарата оптимальным является вакцинный штамм B. anthracis СТИ-1. Чувствительность данной тест-системы по диагностическому титру составляет не менее 1:40 при рабочем разведении ФИТЦ-конъюгата 1:16. Специфичность набора изучали на 100 сыворотках здоровых доноров. Установлено, что 3 % сывороток имели специфическое свечение на 3+ в диагностическом разведении. Подтверждена 100 % воспроизводимость данного метода в разные временные сроки, а также при проведении исследования разными специалистами. Сконструированная тест-система позволяет подтвердить диагноз сибирской язвы у людей.
- 20 December 2013
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 76-78-78
Open AccessConstruction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
Разработана и апробирована тест-система для обнаружения антител к возбудителю сибирской язвы непрямым методом флуоресцирующих антител. Набор включает в себя антигенный препарат, положительный контрольный образец, отрицательный контрольный образец, ФИТЦ-конъюгат кроличьих антител. Изучены 10 акапсульных штаммов B. anthracis с различным плазмидным составом и морфологией колоний. Установлено, что в качестве антигенного препарата оптимальным является вакцинный штамм B. anthracis СТИ-1. Чувствительность данной тест-системы по диагностическому титру составляет не менее 1:40 при рабочем разведении ФИТЦ-конъюгата 1:16. Специфичность набора изучали на 100 сыворотках здоровых доноров. Установлено, что 3 % сывороток имели специфическое свечение на 3+ в диагностическом разведении. Подтверждена 100 % воспроизводимость данного метода в разные временные сроки, а также при проведении исследования разными специалистами. Сконструированная тест-система позволяет подтвердить диагноз сибирской язвы у людей.